nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—HTR1A—Parkinson's disease	0.555	0.625	CbGaD
Alprenolol—CYP2D6—Parkinson's disease	0.333	0.375	CbGaD
Alprenolol—Penbutolol—HTR1A—Parkinson's disease	0.00088	0.146	CrCbGaD
Alprenolol—HTR1A—telencephalic ventricle—Parkinson's disease	0.000808	0.188	CbGeAlD
Alprenolol—Pindolol—HTR1A—Parkinson's disease	0.000634	0.105	CrCbGaD
Alprenolol—Betaxolol—CYP2D6—Parkinson's disease	0.000532	0.0881	CrCbGaD
Alprenolol—Bisoprolol—CYP2D6—Parkinson's disease	0.000514	0.0851	CrCbGaD
Alprenolol—Acebutolol—CYP2D6—Parkinson's disease	0.000487	0.0806	CrCbGaD
Alprenolol—Oxprenolol—CYP2D6—Parkinson's disease	0.000483	0.08	CrCbGaD
Alprenolol—Metoprolol—CYP2D6—Parkinson's disease	0.000411	0.068	CrCbGaD
Alprenolol—HTR1A—hindbrain—Parkinson's disease	0.000382	0.0886	CbGeAlD
Alprenolol—Pindolol—CYP2D6—Parkinson's disease	0.00038	0.063	CrCbGaD
Alprenolol—Atenolol—ABCB1—Parkinson's disease	0.000377	0.0624	CrCbGaD
Alprenolol—Acebutolol—ABCB1—Parkinson's disease	0.000348	0.0576	CrCbGaD
Alprenolol—Propranolol—HTR1A—Parkinson's disease	0.000346	0.0573	CrCbGaD
Alprenolol—Metoprolol—ABCB1—Parkinson's disease	0.000294	0.0486	CrCbGaD
Alprenolol—ADRB1—forebrain—Parkinson's disease	0.000246	0.0571	CbGeAlD
Alprenolol—HTR1A—brainstem—Parkinson's disease	0.000219	0.0508	CbGeAlD
Alprenolol—HTR1A—forebrain—Parkinson's disease	0.000211	0.049	CbGeAlD
Alprenolol—ADRB1—cardiovascular system—Parkinson's disease	0.000208	0.0483	CbGeAlD
Alprenolol—Propranolol—CYP2D6—Parkinson's disease	0.000207	0.0343	CrCbGaD
Alprenolol—CYP2D6—hindbrain—Parkinson's disease	0.000207	0.0481	CbGeAlD
Alprenolol—HTR1A—cardiovascular system—Parkinson's disease	0.000178	0.0414	CbGeAlD
Alprenolol—Propranolol—ABCB1—Parkinson's disease	0.000148	0.0245	CrCbGaD
Alprenolol—ADRB1—head—Parkinson's disease	0.000141	0.0327	CbGeAlD
Alprenolol—HTR1A—midbrain—Parkinson's disease	0.000139	0.0324	CbGeAlD
Alprenolol—HTR1A—spinal cord—Parkinson's disease	0.000136	0.0316	CbGeAlD
Alprenolol—ADRB1—nervous system—Parkinson's disease	0.000134	0.031	CbGeAlD
Alprenolol—ADRB1—central nervous system—Parkinson's disease	0.000129	0.0299	CbGeAlD
Alprenolol—HTR1A—head—Parkinson's disease	0.000121	0.0281	CbGeAlD
Alprenolol—CYP2D6—brainstem—Parkinson's disease	0.000119	0.0276	CbGeAlD
Alprenolol—CYP2D6—forebrain—Parkinson's disease	0.000115	0.0266	CbGeAlD
Alprenolol—HTR1A—nervous system—Parkinson's disease	0.000115	0.0266	CbGeAlD
Alprenolol—HTR1A—central nervous system—Parkinson's disease	0.00011	0.0256	CbGeAlD
Alprenolol—HTR1A—cerebellum—Parkinson's disease	0.000108	0.025	CbGeAlD
Alprenolol—ADRB1—brain—Parkinson's disease	0.000102	0.0237	CbGeAlD
Alprenolol—HTR1A—brain—Parkinson's disease	8.76e-05	0.0203	CbGeAlD
Alprenolol—ADRB3—GPCR downstream signaling—DRD2—Parkinson's disease	8.52e-05	0.000833	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—HTR7—Parkinson's disease	8.52e-05	0.000833	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	8.47e-05	0.000828	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PDYN—Parkinson's disease	8.34e-05	0.000815	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PENK—Parkinson's disease	8.28e-05	0.000809	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	8.23e-05	0.000805	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	8.15e-05	0.000796	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	8.13e-05	0.000795	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—GRM5—Parkinson's disease	8.11e-05	0.000792	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	8.05e-05	0.000787	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—COMT—Parkinson's disease	8.05e-05	0.000786	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	8.01e-05	0.000783	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—ADRBK1—Parkinson's disease	7.99e-05	0.000781	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	7.99e-05	0.000781	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	7.94e-05	0.000776	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	7.94e-05	0.000776	CbGpPWpGaD
Alprenolol—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	7.93e-05	0.000776	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	7.93e-05	0.000775	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	7.92e-05	0.000774	CbGpPWpGaD
Alprenolol—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	7.9e-05	0.000772	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PDYN—Parkinson's disease	7.88e-05	0.00077	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	7.88e-05	0.00077	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	7.76e-05	0.000759	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	7.76e-05	0.000759	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—GRM5—Parkinson's disease	7.75e-05	0.000758	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	7.75e-05	0.000757	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—DRD2—Parkinson's disease	7.74e-05	0.000757	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HTR7—Parkinson's disease	7.74e-05	0.000757	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DGKQ—Parkinson's disease	7.59e-05	0.000742	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GPR37—Parkinson's disease	7.59e-05	0.000742	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PDYN—Parkinson's disease	7.57e-05	0.00074	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—GFAP—Parkinson's disease	7.41e-05	0.000724	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	7.36e-05	0.00072	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	7.36e-05	0.000719	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—GRM5—Parkinson's disease	7.33e-05	0.000716	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	7.26e-05	0.00071	CbGpPWpGaD
Alprenolol—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	7.26e-05	0.000709	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	7.2e-05	0.000704	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	7.17e-05	0.000701	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	7.1e-05	0.000694	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—GRM5—Parkinson's disease	7.04e-05	0.000688	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	7.01e-05	0.000685	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PPP1R1B—Parkinson's disease	6.94e-05	0.000679	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.89e-05	0.000674	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—EDN1—Parkinson's disease	6.86e-05	0.00067	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—EDN1—Parkinson's disease	6.82e-05	0.000667	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.74e-05	0.000659	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.59e-05	0.000644	CbGpPWpGaD
Alprenolol—CYP2D6—head—Parkinson's disease	6.56e-05	0.0152	CbGeAlD
Alprenolol—ADRB3—Signaling Pathways—FGF20—Parkinson's disease	6.42e-05	0.000628	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	6.35e-05	0.00062	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	6.27e-05	0.000613	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	6.26e-05	0.000612	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ADORA2A—Parkinson's disease	6.23e-05	0.000609	CbGpPWpGaD
Alprenolol—CYP2D6—nervous system—Parkinson's disease	6.22e-05	0.0144	CbGeAlD
Alprenolol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	6.21e-05	0.000607	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—EDN1—Parkinson's disease	6.2e-05	0.000606	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	6.13e-05	0.0006	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	6.12e-05	0.000599	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RIT2—Parkinson's disease	6.07e-05	0.000593	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	6.02e-05	0.000588	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—HTR2A—Parkinson's disease	6e-05	0.000586	CbGpPWpGaD
Alprenolol—CYP2D6—central nervous system—Parkinson's disease	5.99e-05	0.0139	CbGeAlD
Alprenolol—HTR1A—Signaling by GPCR—ADORA2A—Parkinson's disease	5.99e-05	0.000585	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	5.98e-05	0.000585	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—HTR2A—Parkinson's disease	5.97e-05	0.000584	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	5.91e-05	0.000578	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	5.89e-05	0.000576	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	5.88e-05	0.000575	CbGpPWpGaD
Alprenolol—CYP2D6—cerebellum—Parkinson's disease	5.85e-05	0.0136	CbGeAlD
Alprenolol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	5.85e-05	0.000572	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	5.78e-05	0.000565	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	5.76e-05	0.000563	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GRK5—Parkinson's disease	5.75e-05	0.000562	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—INSR—Parkinson's disease	5.75e-05	0.000562	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	5.65e-05	0.000552	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—TAC1—Parkinson's disease	5.63e-05	0.000551	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	5.59e-05	0.000547	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD1—Parkinson's disease	5.53e-05	0.00054	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	5.47e-05	0.000535	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—FGB—Parkinson's disease	5.43e-05	0.000531	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	5.43e-05	0.000531	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HTR2A—Parkinson's disease	5.42e-05	0.00053	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR1A—Parkinson's disease	5.41e-05	0.000528	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	5.4e-05	0.000527	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD3—Parkinson's disease	5.35e-05	0.000523	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	5.35e-05	0.000523	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TAC1—Parkinson's disease	5.32e-05	0.00052	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	5.31e-05	0.000519	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	5.28e-05	0.000516	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	5.25e-05	0.000513	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	5.23e-05	0.000511	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.22e-05	0.000511	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD1—Parkinson's disease	5.22e-05	0.00051	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5.22e-05	0.00051	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ND3—Parkinson's disease	5.22e-05	0.00051	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GRM4—Parkinson's disease	5.16e-05	0.000504	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	5.13e-05	0.000502	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—TAC1—Parkinson's disease	5.12e-05	0.0005	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	5.11e-05	0.0005	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	5.11e-05	0.0005	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.11e-05	0.000499	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	5.08e-05	0.000497	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	5.06e-05	0.000495	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	5.06e-05	0.000495	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD3—Parkinson's disease	5.06e-05	0.000494	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD1—Parkinson's disease	5.02e-05	0.00049	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	5e-05	0.000489	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	5e-05	0.000489	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	5e-05	0.000488	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	4.97e-05	0.000486	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	4.95e-05	0.000484	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	4.95e-05	0.000484	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.91e-05	0.000479	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—OMD—Parkinson's disease	4.91e-05	0.000479	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PENK—Parkinson's disease	4.89e-05	0.000478	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAG—Parkinson's disease	4.89e-05	0.000478	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD3—Parkinson's disease	4.86e-05	0.000475	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HTR7—Parkinson's disease	4.84e-05	0.000473	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD2—Parkinson's disease	4.84e-05	0.000473	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	4.77e-05	0.000466	CbGpPWpGaD
Alprenolol—CYP2D6—brain—Parkinson's disease	4.75e-05	0.011	CbGeAlD
Alprenolol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	4.74e-05	0.000464	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ADRBK1—Parkinson's disease	4.72e-05	0.000461	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	4.68e-05	0.000457	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.65e-05	0.000455	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	4.64e-05	0.000454	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	4.59e-05	0.000449	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	4.59e-05	0.000449	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	4.58e-05	0.000447	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD2—Parkinson's disease	4.57e-05	0.000447	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR7—Parkinson's disease	4.57e-05	0.000447	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—ADRBK1—Parkinson's disease	4.54e-05	0.000444	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	4.49e-05	0.000439	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	4.49e-05	0.000439	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDYN—Parkinson's disease	4.47e-05	0.000437	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.44e-05	0.000434	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	4.4e-05	0.00043	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD2—Parkinson's disease	4.39e-05	0.00043	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR7—Parkinson's disease	4.39e-05	0.00043	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	4.35e-05	0.000425	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	4.3e-05	0.000421	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	4.25e-05	0.000416	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GFAP—Parkinson's disease	4.21e-05	0.000411	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GRM5—Parkinson's disease	4.16e-05	0.000407	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	4.05e-05	0.000396	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	3.96e-05	0.000387	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.95e-05	0.000386	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—DBH—Parkinson's disease	3.95e-05	0.000386	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GBA—Parkinson's disease	3.95e-05	0.000386	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—EDN1—Parkinson's disease	3.87e-05	0.000379	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IGF2—Parkinson's disease	3.83e-05	0.000375	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	3.81e-05	0.000373	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	3.73e-05	0.000365	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IGF1R—Parkinson's disease	3.7e-05	0.000362	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	3.7e-05	0.000361	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	3.68e-05	0.00036	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EDN1—Parkinson's disease	3.66e-05	0.000358	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	3.65e-05	0.000357	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	3.62e-05	0.000354	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	3.6e-05	0.000352	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	3.54e-05	0.000346	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	3.54e-05	0.000346	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	3.52e-05	0.000344	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	3.47e-05	0.000339	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	3.41e-05	0.000334	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	3.39e-05	0.000331	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NGF—Parkinson's disease	3.36e-05	0.000329	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	3.34e-05	0.000326	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—INSR—Parkinson's disease	3.26e-05	0.000319	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	3.23e-05	0.000315	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	3.22e-05	0.000315	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	3.21e-05	0.000314	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR2A—Parkinson's disease	3.2e-05	0.000313	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	3.16e-05	0.000309	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	3.16e-05	0.000308	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	3.15e-05	0.000308	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	3.14e-05	0.000307	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	3.1e-05	0.000303	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	3.09e-05	0.000302	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FGB—Parkinson's disease	3.09e-05	0.000302	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	3.08e-05	0.000301	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	3.03e-05	0.000296	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	3.02e-05	0.000295	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	3e-05	0.000293	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APOE—Parkinson's disease	2.98e-05	0.000291	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	2.96e-05	0.00029	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	2.94e-05	0.000287	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—DDC—Parkinson's disease	2.9e-05	0.000284	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	2.87e-05	0.000281	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	2.8e-05	0.000274	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	2.74e-05	0.000268	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.74e-05	0.000268	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	2.71e-05	0.000265	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	2.71e-05	0.000265	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	2.68e-05	0.000262	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	2.65e-05	0.00026	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	2.65e-05	0.00026	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	2.6e-05	0.000254	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	2.6e-05	0.000254	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—INS—Parkinson's disease	2.54e-05	0.000249	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.47e-05	0.000241	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.44e-05	0.000239	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	2.27e-05	0.000222	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	2.22e-05	0.000217	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	2.2e-05	0.000215	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	2.18e-05	0.000213	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	2.17e-05	0.000212	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	2.15e-05	0.00021	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	2.13e-05	0.000208	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	2.1e-05	0.000206	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	2.08e-05	0.000203	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	2e-05	0.000195	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	1.95e-05	0.000191	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NGF—Parkinson's disease	1.91e-05	0.000187	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	1.9e-05	0.000186	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CASP3—Parkinson's disease	1.89e-05	0.000185	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—Parkinson's disease	1.88e-05	0.000184	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	1.86e-05	0.000182	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	1.82e-05	0.000178	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.78e-05	0.000174	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	1.77e-05	0.000173	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MAPK8—Parkinson's disease	1.74e-05	0.00017	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	1.73e-05	0.000169	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOE—Parkinson's disease	1.69e-05	0.000165	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.66e-05	0.000162	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.64e-05	0.00016	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TH—Parkinson's disease	1.62e-05	0.000158	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.55e-05	0.000152	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—INS—Parkinson's disease	1.51e-05	0.000148	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—INS—Parkinson's disease	1.48e-05	0.000144	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—INS—Parkinson's disease	1.44e-05	0.000141	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—COMT—Parkinson's disease	1.38e-05	0.000134	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.37e-05	0.000134	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.37e-05	0.000134	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.35e-05	0.000132	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.3e-05	0.000127	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.26e-05	0.000123	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.21e-05	0.000118	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	1.12e-05	0.00011	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	1.12e-05	0.000109	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.11e-05	0.000109	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—Parkinson's disease	1.11e-05	0.000109	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	1.1e-05	0.000107	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	1.09e-05	0.000107	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	1.08e-05	0.000105	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	1.07e-05	0.000104	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOE—Parkinson's disease	1.04e-05	0.000101	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	1.03e-05	0.000101	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	1.01e-05	9.88e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	9.88e-06	9.66e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—INS—Parkinson's disease	8.84e-06	8.65e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	6.6e-06	6.45e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	6.45e-06	6.31e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—Parkinson's disease	6.31e-06	6.17e-05	CbGpPWpGaD
